Search Results

Test Catalog

GIAR - Overview: Giardia Antigen, Feces

Sensitive screening for the detection of Giardia antigens present in fecal specimens

LEGRP - Overview: Legionella species, Molecular Detection, PCR, Varies

Sensitive and rapid diagnosis of pneumonia caused by Legionella species The assay is not recommended as a test of cure because bacteria nucleic acids may persist after successful treatment.

INAB - Overview: Insulin Antibodies, Serum

Predicting the future development of type 1 diabetes in asymptomatic children, adolescents, and young adults, when used in conjunction with family history, human leukocyte antigen-typing, and other autoantibodies, including glutamic acid...

NBILI - Overview: Neonatal Bilirubin, Serum

Assessing liver function Evaluating a wide range of diseases affecting the production, uptake, storage, metabolism, or excretion of bilirubin Monitoring the efficacy of neonatal phototherapy

SSCTU - Overview: S-Sulfocysteine Panel, Urine

Diagnosis of molybdenum cofactor deficiency, isolated sulfite oxidase deficiency, and hereditary xanthinuria Monitoring patients with molybdenum cofactor deficiency or isolated sulfite oxidase deficiency who are on treatment

Site Search

Category A - Mayo Clinic Laboratories

How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......

Guidance on subtyping of influenza A test results - Insights

Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...

Category A Infectious Substances - Mayo Clinic Laboratories

Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...

Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights

In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....

Utilization Practices for Venous Thromboembolism: A Model of Cost Savings and Efficiency at Mayo Clinic...

A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...